ArticleScientific reports2024

Cetuximab inhibits colorectal cancer development through inactivating the Wnt/β-catenin pathway and modulating PLCB3 expression.

Xiaohong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.